James Paul Scopa - 25 Oct 2023 Form 4 Insider Report for Aligos Therapeutics, Inc. (ALGS)

Role
Director
Signature
/s/ Lucinda Y. Quan, as attorney-in fact for James Scopa
Issuer symbol
ALGS
Transactions as of
25 Oct 2023
Net transactions value
+$150,000
Form type
4
Filing time
27 Oct 2023, 16:13:06 UTC
Previous filing
09 Aug 2023
Next filing
09 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALGS Common Stock Award $138,557 +183,083 $0.7568 183,083 25 Oct 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALGS Warrant (Right to Buy) Award $11,443 +91,541 $0.1250* 91,541 25 Oct 2023 Common Stock 91,541 $0.7568 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.